Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers

Clinical trial NCT02497820 · NOT_YET_RECRUITING

Trial details

NCT number: NCT02497820
Sponsor: Tel-Aviv Sourasky Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lynch Syndrome I (Site-specific Colonic Cancer)

Start date: 2016-09-01
Primary completion: 2027-09-01
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.